Baillière's clinical haematology
-
Baillieres Clin. Haematol. · Jul 1990
Review Randomized Controlled Trial Multicenter Study Clinical TrialFibrinolytic therapy in coronary artery disease.
-
Baillieres Clin. Haematol. · Jul 1990
Review Multicenter Study Clinical TrialAntithrombotic treatment of cerebrovascular disease.
The most common type of cerebrovascular disease is ischaemia or infarction from atherothrombosis or cardiac embolism. Antithrombotic treatment with an antiplatelet agent or anticoagulant assumes a prior clinical classification into categories of transient ischaemic attack (TIA) or minor stroke, acute partial stable stroke, stroke-in-progression, and completed stroke. Aspirin reduces the risk of stroke, myocardial infarction, and death after TIA or minor stroke secondary to atherothrombosis. ⋯ Long-term anticoagulation of patients after the hospital phase of myocardial infarction reduces the incidence of systemic embolism/stroke, recurrent myocardial infarction and death. Prophylactic anticoagulant treatment of patients with non-valvular atrial fibrillation reduces the incidence of embolism, but the optimal duration of treatment is not known. Immediate anticoagulation of patients with completed cardioembolic stroke is safe and effective in preventing recurrent embolism.
-
Baillieres Clin. Haematol. · Jul 1990
Review Randomized Controlled Trial Multicenter Study Clinical TrialAntithrombotic therapy for coronary artery disease and valvular heart disease.